Nasdaq
KZIA
Kazia Therapeutics Limited
- Health Care
- Australia
- 1 day
- +2.8%
- 1 month
- −5.9%
- 1 year
- +42.2%
$12.33 · Mkt cap $141M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Kazia Therapeutics Limited
$12.33 · Mkt cap $141M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Kazia Therapeutics Limited trades under the ticker KZIA on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $141M. The last closing price was $12.33, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +42.2%, and −5.9% over the past month. Returns are price returns and exclude dividends.
This page exists because KZIA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.